Understanding Drug Development in Sickle Cell – From Research to Access
A Collaboration with Pfizer Inc.
Understanding Drug Development in Sickle Cell is a collaborative educational initiative between Sickle Cell 101 and Pfizer Inc. created to close knowledge gaps in the sickle cell community about the complex journey of drug development. Through Sickle Cell 101’s digital platforms, this initiative will explain each step of the process, from clinical trials to regulatory approval and treatment access. Content is presented in clear, accessible language to help patients, caregivers, and advocates understand how new therapies are developed and made available. This collaboration is rooted in trust, transparency, and empowerment. It builds understanding of the drug development process, strengthens trust between the community and drug developers, and provides timely insights into the evolving research and treatment landscape.
More About Research to Access: Understanding Drug Development in Sickle Cell
Initiative Key Topics
The initiative’s key topics highlight the essential
stages of drug development in sickle cell disease:
- The Drug Development Journey
Covers why drug development matters in
sickle cell disease, the phases of clinical
trials, and how new treatments are
discovered and tested. - Regulatory Pathways and Patient
Advocacy
Explains FDA designations, approvals, and
incentives, while highlighting how patient
engagement and advocacy help shape
more meaningful treatments and improve
transparency in the process. - Life After Approval: Safety and Access
Explores what happens once a drug is
approved, including post-market studies,
long-term safety monitoring, and drug
withdrawals, ensuring treatments remain
effective and patients stay safe.
Initiative Components
From Research to Access: Understanding Drug Development in Sickle Cell initiative will break down this journey through the following components:
Events: Informational podcasts, lives and webinars presenting the evidence-based insights on clinical trials, regulatory pathways, and access considerations from leading medical experts.
Fact sheet: Downloadable and printable fact sheets summarizing the stages of drug development, types of approvals, safety monitoring, and pathways to patient access.
Ask the Experts Live: Moderated online community forums for patients and families to ask questions and share experiences.
Social media campaign: A social media campaign supplying campaign updates and patient-friendly education on drug development processes.
[To be determined by Pfizer]
[To be determined by Pfizer]
[To be determined by Pfizer]
About Our Collaborator: Pfizer Inc.
Our sincere thanks to Pfizer, our collaborator for the Understanding Drug Development in Sickle Cell educational initiative. Their support helps us provide the sickle cell community with comprehensive and accurate information Understanding Drug Development in Sickle Cell. By working together, we can ensure that individuals, families, and providers have access to the education and resources they need to navigate research for sickle cell.
[To be determined by Pfizer]
